You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 31, 2024

Details for New Drug Application (NDA): 210875


✉ Email this page to a colleague

« Back to Dashboard


NDA 210875 describes KYNMOBI, which is a drug marketed by Sumitomo Pharma Am and is included in one NDA. There are fourteen patents protecting this drug. Additional details are available on the KYNMOBI profile page.

The generic ingredient in KYNMOBI is apomorphine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
Summary for 210875
Tradename:KYNMOBI
Applicant:Sumitomo Pharma Am
Ingredient:apomorphine hydrochloride
Patents:14
Medical Subject Heading (MeSH) Categories for 210875

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:FILM;SUBLINGUALStrength10MG
Approval Date:May 21, 2020TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Jun 11, 2030Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE
Patent:⤷  Sign UpPatent Expiration:Apr 19, 2036Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF 'OFF' EPISODES IN PATIENTS WITH PARKINSON'S DISEASE
Patent:⤷  Sign UpPatent Expiration:Aug 7, 2029Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 210875

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-002 May 21, 2020 ⤷  Sign Up ⤷  Sign Up
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-001 May 21, 2020 ⤷  Sign Up ⤷  Sign Up
Sumitomo Pharma Am KYNMOBI apomorphine hydrochloride FILM;SUBLINGUAL 210875-005 May 21, 2020 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.